Clinical Trial Update: Supplementation With Nutrients Modulating IGF-1 and Cytokines in Elderly People at Risk of Undernutrition [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating supplementation with nutrients purported to modulate IGF-1 and cytokines in elderly people at risk of undernutrition has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Undernutrition

Snippet

Sponsor: Yonsei University | Conditions: Undernutrition | Phase 3 | Status: COMPLETED